WitrynaIMU UNATTRACTIVE : Imugene's dividend yield of 0.0% is less than the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. Dividend Yield explained Implied Growth 40.7% 11.7% Industry Avg IMU Witryna29 lis 2024 · Created with Sketch. ASX - By Stock. ASX - Day Trading
Prescient Therapeutics Ltd (ASX:PTX) Share Price - Market Index
Witryna2 maj 2024 · Imugene shares reached an all-time high of 62.5 cents in November, before shifting to a downhill trend. Based on today’s price, Imugene has a market capitalisation of roughly $1.12 billion with approximately 5.85 billion shares on issue. Witryna5 kwi 2024 · IMU Substantial Shareholders Under ASX rules large investors and … imaging center of staten island
IMU share price and company information for ASX:IMU
WitrynaHER-Vaxx is a B-cell immuno-therapy designed to treat tumours that over-express the HER-2/neu receptor, such as gastric, breast, ovarian, lung and pancreatic cancers. PD1-Vaxx is a B-cell immuno-therapy which aims to induce the body to produce polyclonal antibodies that block PD-1 signalling, and thus produce an anticancer effect similar to ... Top 20 Shareholders About the Data Show All Shareholder Distribution As reported in the most recent Annual Report. Substantial Shareholders No Substantial Shareholders for IMU in our database. Shareholders Buying 12 month transaction history compiled from ASX announcements. Witryna28 cze 2024 · A Top 20 Shareholder List as set out in Listing Rule 4.10.9; and A Distribution Schedule as set out in Listing Rule 4.10.7. ENDS Further Information For further information, please contact Joe Walsh Tom Dukovcic Managing Director Exploration Director Lepidico Ltd Lepidico Ltd Tel: +61 (0)8 9363 7800 imaging center of idaho teton